Bristol Myers Squibb (BMY) Assets Average (2016 - 2026)

Bristol Myers Squibb has reported Assets Average over the past 17 years, most recently at $88.3 billion for Q1 2026.

Quarterly Assets Average fell 4.6% to $88.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $88.3 billion through Mar 2026, down 4.6% year-over-year, with the annual reading at $91.3 billion for FY2025, 2.73% down from the prior year.
Assets Average was $88.3 billion for Q1 2026 at Bristol Myers Squibb, down from $93.5 billion in the prior quarter.
Over five years, Assets Average peaked at $106.2 billion in Q1 2022 and troughed at $88.3 billion in Q1 2026.
The 5-year median for Assets Average is $94.2 billion (2024), against an average of $95.6 billion.
Year-over-year, Assets Average decreased 11.44% in 2022 and then rose 3.15% in 2024.
A 5-year view of Assets Average shows it stood at $97.5 billion in 2022, then dropped by 4.41% to $93.2 billion in 2023, then fell by 0.08% to $93.1 billion in 2024, then grew by 0.35% to $93.5 billion in 2025, then decreased by 5.57% to $88.3 billion in 2026.
Per Business Quant, the three most recent readings for BMY's Assets Average are $88.3 billion (Q1 2026), $93.5 billion (Q4 2025), and $95.8 billion (Q3 2025).

Peer Comparison